HealthTech 250: A decision-grade shortlist of digital health ventures—built from evidence, not hype
An evidence-led shortlist of digital health ventures—built for faster shortlisting, benchmarking, and partner scouting.
The 2026 HealthTech 250 identifies high-momentum ventures using a transparent, signal-based methodology across funding, commercial partnerships, and evidence.
Download the 2026 HealthTech 250
Access the full intelligence layer in HealthTech Alpha

Digital health companies tracked
~1.5 billion
Data Points Analyzed
$1.6 billion
Raised by HT250 Ventures in 2025
Strategic Partnerships
What you get in the HealthTech 250 (2026) Download
The HealthTech 250 early-stage digital health startups list is organized in five XLSX lists designed for quick shortlisting, benchmarking, and outreach planning
United States
Top early-stage digital health ventures headquartered in the US, including top-funded deals such as Function Health ($298M).
Asia Pacific
Digital health innovators across Singapore, India, Japan, and Australia driving telehealth, diagnostics, and AI-powered care delivery.
Europe
Leading early-stage startups from the UK, France, Germany, Nordics, and Southern Europe building the next generation of health infrastructure.
Rest of the World
High-potential ventures from Israel, Africa, Latin America, and the Middle East addressing healthcare access and diagnostic gaps.
Top Clusters
The 3 leading innovation clusters across the HealthTech 250, with key trends, representative ventures, and average funding data.
Get Access To All Data
Contact us to access the full HealthTech 250 dataset and the complete HealthTech Alpha platform.
Want the full universe beyond the HT250? HealthTech Alpha lets you expand the shortlist into a complete market map.
Download the 2026 HealthTech 250 Lists. The lists available include: 2026 HealthTech 250 - Top Digital Health Startups in United States 2026 HealthTech 250 - Top Digital Health Startups in Europe 2026 HealthTech 250 - Top Digital Health Startups in Asia Pacific 2026 HealthTech 250 - Top Digital Health Startups in Rest of the World 2026 HealthTech 250 - Key Clusters
Complete the form to access the lists aligned with your interest.What the 2026 HealthTech 250 is Signalling
Three shifts stand out in this year’s selection.Resilience is the new moat
The most credible ventures are showing durability across capital, commercial traction, and evidence—not just fundraising.Evidence signals are back in focus
Clinical validation and real-world adoption are increasingly differentiators as buyers tighten procurement standards.Infrastructure is quietly winning
Enablers—workflow, data, and distribution layers—are scaling alongside care delivery and condition-led solutions.HealthTech 250 is the Shortlist. HealthTech Alpha is the Engine
The HealthTech 250 is designed for fast signal capture. HealthTech Alpha is what teams use when they need repeatable, board-ready intelligence at scale.Expand Beyond 250
Build market maps from the full venture universe and filter by theme, geography, stage, and signal strength.Validate faster
Compare ventures using evidence, partnerships, funding momentum, and competitive context.Operationalize scouting
Export shortlists, track momentum, and create repeatable workflows for BD, strategy, and investment teams.Purpose & Scope
Data Sources & Signals
Data Source: HealthTech Alpha
Timeframe of Analysis
Definitions
Scoring and Selection Process
Selection Framework (High-Level)
How to Use This Dataset
Universe Definition
Stage 1 – Waterfall Filtering
Stage 2 – Weighted Analysis & Geography Normalization
| Metric | Weight | Description |
|---|---|---|
| 2025 Relevance | 25% | Alignment with top trending Digital Health themes of 2025. |
| Alpha Score | 15% | Proprietary composite maturity assessment. |
| Clinical Evidence Signal | 15% | Assessment of validation and regulatory progress. |
| Funding Value Percentile | 10% | Capital raised percentile relative to stage and geography. |
| Funding Velocity | 10% | Speed of capital accumulation since incorporation. |
| Partnership Signal | 10% | Measured ecosystem engagement activity. |
| Health Check | 15% | Composite structural robustness indicator. |
Adjustments vs Previous Edition
Scoring Outcome
Important Notes
FAQs
Who Is It For?
Clusters & Therapeutic Areas
The cohort reflects a balance between disease-specific innovation and cross-therapeutic platforms, with a substantial share of startups operating in a disease-agnostic capacity. Among targeted areas, Oncology leads (16%), followed by Women’s Health (8%) and Mental Health (6%), with Cardiovascular and Wellness each at 5%. From a solution perspective, Health Management Solutions (24%) dominate, followed by Medical Diagnostics (16%) and Research Solutions (15%). Smaller but relevant clusters include Patient Solutions (8%), Wellness (7%), and Telemedicine (6%), reflecting a shift toward outcome-driven, infrastructure-oriented models.
Leading Digital Health Categories
The HealthTech 250 spans a broad range of digital health categories, with strong representation in health management solutions, diagnostics, and research. Compared with prior years, the 2026 cohort shows a clear shift toward ventures that integrate directly into clinical workflows or enable measurable operational improvements for healthcare providers, payers, and life sciences companies.Therapeutic Area Distribution
From a therapeutic perspective, the 2026 cohort is led by oncology, women’s health, mental health, and cardiometabolic conditions. These areas combine large patient populations with clear unmet needs and strong commercial interest, making them attractive for both investors and strategic partners. The distribution reflects a broader industry trend toward condition-specific solutions that demonstrate clinical impact and economic value.Funding Landscape
The cohort raised approximately USD 1.5--1.6 billion with an average deal size of USD 26.3 million. As of January 2026, the cohort maintains a 96% survival rate. Stand-out rounds include Function Health ($298M), Profluent ($106M), Paradigm ($78M), Nourish ($70M), and CertifyOS ($40M).
